Iov Istituto Oncologico Veneto Irccs
Iov Istituto Oncologico Veneto Irccs
Padova, Italy4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Simpson-Golabi-Behmel syndrome, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT06427941 | |
| Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, desmoplastic small round cell tumor, neoplasm, sarcoma | Recruiting | Phase 2 | 2026-09-02 | NCT07328425 | |
| Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, angiosarcoma, neoplasm, sarcoma, vascular cancer | Recruiting | Not stated | 2025-11-20 | NCT06375941 | |
| A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib | ALK Gene Mutation; Non Small Cell Lung Cancer Metastatic | Recruiting | Phase 2 | 2024-04-23 | NCT06378892 |